C G Gjesdal
Overview
Explore the profile of C G Gjesdal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alsing C, Nystad T, Igland J, Gjesdal C, Midtbo H, Tell G, et al.
Scand J Rheumatol
. 2022 Mar;
52(3):233-242.
PMID: 35272584
Objective: To evaluate trends of acute myocardial infarction (AMI) and ischaemic heart disease (IHD) in rheumatoid arthritis (RA) patients compared with the general population over time. Method: We performed a...
2.
Brekke L, Fevang B, Diamantopoulos A, Assmus J, Espero E, Gjesdal C
Arthritis Res Ther
. 2019 Jun;
21(1):154.
PMID: 31238961
Background: Our objective was to determine the survival and causes of death in a large and well-characterized cohort of patients with giant cell arteritis (GCA). Methods: This is a hospital-based,...
3.
Brekke L, Diamantopoulos A, Fevang B, ABmus J, Espero E, Gjesdal C
Arthritis Res Ther
. 2018 Dec;
20(1):271.
PMID: 30526639
Following publication of the original article [1], the authors reported an error.
4.
Brekke L, Diamantopoulos A, Fevang B, ABmus J, Espero E, Gjesdal C
Arthritis Res Ther
. 2017 Dec;
19(1):278.
PMID: 29246164
Background: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have been reported in Scandinavian countries....
5.
Bader L, Solberg S, Kaada S, Bolstad N, Warren D, Gavasso S, et al.
Scand J Immunol
. 2017 Jun;
86(3):165-170.
PMID: 28561325
Immunogenicity is a frequent cause of secondary non-response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug antibodies have been shown to be cost effective and...
6.
Steihaug O, Gjesdal C, Bogen B, Ranhoff A
J Nutr Health Aging
. 2016 Aug;
20(7):685-90.
PMID: 27499300
Background: Older hip fracture patients often have reduced muscle mass, which is associated with adverse outcomes. Dual energy X-ray absorptiometry (DXA) can determine muscle mass, but is not practical in...
7.
Sogaard A, Holvik K, Meyer H, Tell G, Gjesdal C, Emaus N, et al.
Osteoporos Int
. 2016 Feb;
27(7):2217-2222.
PMID: 26902091
Unlabelled: The previously reported decline in age-adjusted hip fracture rates in Norway during 1999-2008 continued after 2008. The annual number of hip fractures decreased in women and increased in men....
8.
Oyen J, Svingen G, Gjesdal C, Tell G, Ueland P, Lysne V, et al.
Osteoporos Int
. 2015 Jan;
26(5):1573-83.
PMID: 25616506
Unlabelled: In the large community-based Hordaland Health Study, low plasma dimethylglycine was associated with low bone mineral density in both middle-aged and elderly subjects and to an increased risk of...
9.
Holvik K, Gjesdal C, Tell G, Grimnes G, Schei B, Apalset E, et al.
Osteoporos Int
. 2014 Jul;
25(11):2545-54.
PMID: 25062727
Unlabelled: We investigated the risk of hip fracture according to circulating alpha-tocopherol, a plant-derived substance with antioxidant properties, in community-dwelling older Norwegians. We found a linear increasing risk of hip...
10.
Apalset E, Gjesdal C, Ueland P, Oyen J, Meyer K, Midttun O, et al.
Osteoporos Int
. 2014 May;
25(8):2067-75.
PMID: 24817202
Unlabelled: The cytokine interferon gamma (IFN-γ) stimulates neopterin release and tryptophan degradation into kynurenines through the kynurenine pathway. High levels of neopterin were associated with increased hip fracture risk, as...